[en] INTRODUCTION: Parkinson's disease (PD) has become the second most prevalent neurodegenerative condition after Alzheimer's. It is a chronic, progressive and disabling disorder characterized by motor and non-motor symptoms, with tremor, bradykinesia, rigidity and postural impairment being the most relevant. These manifestations cause limitations in the autonomy of patients, leading to a deterioration in their quality of life. The aetiology is not completely defined and its diagnosis is made by the clinic, which makes it difficult to intervene quickly. As for the treatment, it is mainly pharmacological, but it is complemented, with precise indications, with surgical techniques or different therapies, such as dance. MAIN OBJECTIVE: The main objective of this study is to determine the effectiveness of dance as a treatment for different motor, psychological and social disorders in mild-moderate PD patients. METHODOLOGY: It is proposed to develop a randomized and open controlled clinical trial. Subjects will belong to the Asociación Parkinson Ferrol or Galicia-Coruña and will be selected if they present IQ and meet the established criteria, where it is clarified that the severity of PD must be between stage I-III according to the Hoehn and Yahr scale. A total of 60 patients will participate, which will be established in a random and homogeneous way to one of the three groups. One of the groups will be the GC, where physiotherapeutic exercises will be performed. The other two will be GI and will practice dance as therapy, one TA and one waltz. The intervention will last 12 months, in the first one education classes will be carried out and in the following 11 months they will carry out the therapy that has been established for them. The evaluation will be done before starting the intervention, 3 and 6 months after starting it, at the end of it and 3 months after its completion. The variables and the instruments that will be used to measure them are the following: severity of the disease (Hoehn and Yhar stages), balance (Berg's Balance Scale), walking (6MWT Test, TUG), motor function (MDS-UPDRS-III), cognitive impairment (MoCA), quality of life (PDQ-39, BDI) and therapeutic satisfaction (by means of a questionnaire of own elaboration).

[gl] INTRODUCIÓN: A enfermidade de Parkinson (EP) converteuse na segunda afección neurodegenerativa de maior prevalencia despois do Alzheimer. Trátase dun trastorno crónico, progresivo e incapacitante caracterizado por síntomas motores e non motores, onde o tremor, a bradicinesia, a rixidez e a alteración postural son os máis relevantes. Estas manifestacións causan limitacións na autonomía dos pacientes, provocando un deterioro da súa calidade de vida. A etiología non está totalmente concretada e a súa diagnóstico realízase mediante a clínica, o que dificulta unha rápida intervención. En canto ao tratamento, é principalmente farmacológico, pero se complementa, con indicacións precisas, con técnicas quirúrgicas ou diferentes terapias, como a danza. OBXECTIVO PRINCIPAL: O obxectivo principal deste estudo é determinar a eficacia da danza como tratamento de diferentes alteracións motoras, psicolóxicas e sociais en pacientes con EP en estadio leve-moderado. METODOLOXÍA: Proponse desenvolver un ensaio clínico controlado aleatorizado e aberto. Os suxeitos pertencerán á Asociación Parkinson Ferrol ou Galicia-Coruña e serán seleccionados si presentan o CI e cumpren os criterios establecidos, onde se aclara que a severidad da EP debe atoparse entre o estadio I-III segundo a escala de Hoehn e Yahr. Participarán un total de 60 pacientes, os cales, serán establecidos de xeito aleatoria e homogénea a un dos tres grupos Uno dos grupos será o GC, onde se realizarán exercicios fisioterapéuticos. Os outros dous, serán GI e practicarán danza como terapia, un TA e outro vals. A intervención terá unha duración de 12 meses, no primeiro levaranse a cabo clases de educación e nos posteriores 11 meses realizarán a terapia que se lles estableceu. A avaliación farase antes de comezar a intervención, aos 3 e 6 meses de iniciar, ao finalizala e 3 meses logo do seu finalización. As variables e os instrumentos que se utilizarán para medilas son os seguintes: severidad dela enfermidade (Estadíos de Hoehn e Yhar), o equilibrio (Escala de Equilibrio de Berg), a marcha (Test 6MWT, TUG), a función motora (MDS-UPDRS-III), o deterioro cognitivo (MoCA), a calidade de vida (PDQ-39, BDI) e a satisfacción terapéutica (mediante un cuestionario de elaboración propia).